ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 11 | -100.0% | 0.00% | – |
| Q1 2018 | $175,000 | +2816.7% | 352,030 | +6816.1% | 0.00% | – |
| Q4 2017 | $6,000 | -94.1% | 5,090 | -94.3% | 0.00% | – |
| Q3 2017 | $101,000 | -29.9% | 88,543 | +46.8% | 0.00% | – |
| Q2 2017 | $144,000 | +23.1% | 60,308 | +30.5% | 0.00% | – |
| Q1 2017 | $117,000 | -10.7% | 46,224 | +0.2% | 0.00% | – |
| Q4 2016 | $131,000 | +23.6% | 46,111 | +22.3% | 0.00% | – |
| Q3 2016 | $106,000 | -2.8% | 37,711 | 0.0% | 0.00% | – |
| Q2 2016 | $109,000 | -16.2% | 37,711 | +0.0% | 0.00% | – |
| Q1 2016 | $130,000 | -25.7% | 37,700 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | +41.1% | 37,700 | +50.2% | 0.00% | – |
| Q3 2015 | $124,000 | – | 25,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 778,211 | $2,700,000 | 0.34% |
| NEA Management Company, LLC | 1,460,209 | $5,067,000 | 0.34% |
| Tekla Capital Management LLC | 811,227 | $2,783,000 | 0.12% |
| ROYCE & ASSOCIATES LP | 179,757 | $617,000 | 0.00% |
| Virtu KCG Holdings LLC | 15,690 | $54,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,216,840 | $4,174,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 142 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 37,700 | $130,000 | 0.00% |
| CITIGROUP INC | 5 | $0 | 0.00% |
| Walleye Trading LLC | 1,100 | $4,000 | 0.00% |